OA12917A - Novel Polymorph of N-Methyl-N-(3-{3-[2-Thienylcarbonyl]-Pyrazol-[1,5-alpha]-Pyrimidin-7-YL}Pheny) Acetamide and Compositions and Methods Related thereto. - Google Patents

Novel Polymorph of N-Methyl-N-(3-{3-[2-Thienylcarbonyl]-Pyrazol-[1,5-alpha]-Pyrimidin-7-YL}Pheny) Acetamide and Compositions and Methods Related thereto. Download PDF

Info

Publication number
OA12917A
OA12917A OA1200500060A OA1200500060A OA12917A OA 12917 A OA12917 A OA 12917A OA 1200500060 A OA1200500060 A OA 1200500060A OA 1200500060 A OA1200500060 A OA 1200500060A OA 12917 A OA12917 A OA 12917A
Authority
OA
OAPI
Prior art keywords
composition
polymorph form
weight
compound
polymorph
Prior art date
Application number
OA1200500060A
Other languages
English (en)
Inventor
Scott E Zook
Donald Hettinger
Henry R Dubois Iii
Original Assignee
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurocrine Biosciences Inc filed Critical Neurocrine Biosciences Inc
Publication of OA12917A publication Critical patent/OA12917A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
OA1200500060A 2002-08-26 2003-08-26 Novel Polymorph of N-Methyl-N-(3-{3-[2-Thienylcarbonyl]-Pyrazol-[1,5-alpha]-Pyrimidin-7-YL}Pheny) Acetamide and Compositions and Methods Related thereto. OA12917A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40607202P 2002-08-26 2002-08-26

Publications (1)

Publication Number Publication Date
OA12917A true OA12917A (en) 2006-10-13

Family

ID=31946959

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200500060A OA12917A (en) 2002-08-26 2003-08-26 Novel Polymorph of N-Methyl-N-(3-{3-[2-Thienylcarbonyl]-Pyrazol-[1,5-alpha]-Pyrimidin-7-YL}Pheny) Acetamide and Compositions and Methods Related thereto.

Country Status (31)

Country Link
US (2) US6903106B2 (de)
EP (1) EP1532152B1 (de)
JP (2) JP4522859B2 (de)
KR (1) KR101063033B1 (de)
CN (1) CN1319974C (de)
AP (1) AP2005003220A0 (de)
AR (1) AR044191A1 (de)
AT (1) ATE343581T1 (de)
AU (1) AU2003268212B2 (de)
BR (1) BR0313695A (de)
CA (1) CA2493359C (de)
DE (1) DE60309332T2 (de)
DK (1) DK1532152T3 (de)
EA (1) EA200500421A1 (de)
EC (1) ECSP055703A (de)
ES (1) ES2274260T3 (de)
HR (1) HRP20050288A2 (de)
IL (2) IL166621A0 (de)
IS (1) IS7769A (de)
MA (1) MA27519A1 (de)
MX (1) MXPA05002251A (de)
NO (1) NO20050615L (de)
NZ (1) NZ538027A (de)
OA (1) OA12917A (de)
PE (1) PE20040979A1 (de)
PL (1) PL374436A1 (de)
PT (1) PT1532152E (de)
TN (1) TNSN05058A1 (de)
TW (1) TWI288135B (de)
WO (1) WO2004018476A1 (de)
ZA (1) ZA200501125B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003268212B2 (en) * 2002-08-26 2008-08-14 Neurocrine Biosciences, Inc. Novel polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-YL}phenyl)acetamide and compositions and methods related thereto
US7429596B2 (en) * 2003-06-20 2008-09-30 The Regents Of The University Of California 1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof
EP1844047A1 (de) * 2004-10-18 2007-10-17 Neurocrine Biosciences, Inc. Hydrat von n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamid und verfahren zur herstellung davon
CN100528875C (zh) * 2005-02-18 2009-08-19 美德(江西)生物科技有限公司 无结晶型态的印地普隆及其制备方法
EP1956021A1 (de) * 2006-10-11 2008-08-13 Ferrer Internacional, S.A. Verfahren zur Herstellung von Crystallin pyrazol[1,5-a]pyrimidin Verbindung
EP1918290A1 (de) * 2006-10-11 2008-05-07 Ferrer Internacional, S.A. Polymprph B von N-{2-Fluor-5-[3-(thiophen-2-carbonyl)-pyrazolo[1,5-a]pyrimidin-7-yl]phenyl}-N-methyl-acetamid
CN102180879B (zh) * 2006-11-09 2013-05-01 中国人民解放军军事医学科学院放射与辐射医学研究所 一种催眠药的多晶型α的乙酸溶剂化物
CN101177427B (zh) * 2006-11-09 2011-07-20 中国人民解放军军事医学科学院放射与辐射医学研究所 一种用于催眠的化合物的多晶型α和溶剂化物,其制备方法及含该物质的组合物
AT507187B1 (de) 2008-10-23 2010-03-15 Helmut Dr Buchberger Inhalator
JP5542238B2 (ja) 2010-03-25 2014-07-09 矢崎総業株式会社 ジョイントコネクタ及びジョイントコネクタにおけるバスバーパターン識別方法
PT2377830T (pt) * 2010-04-16 2016-07-18 Ivoclar Vivadent Ag Vidro cerâmico de silicato de lítio e vidro de silicato de lítio, contendo óxido de metal de transição
CA2824970C (en) 2011-02-11 2016-05-03 Batmark Limited Inhaler component
AT510837B1 (de) 2011-07-27 2012-07-15 Helmut Dr Buchberger Inhalatorkomponente
CN102174048B (zh) * 2011-03-08 2014-09-17 中国人民解放军军事医学科学院放射与辐射医学研究所 一种催眠药的新多晶型β
MY164560A (en) 2011-09-06 2018-01-15 British American Tobacco Investments Ltd Heating Smokeable Material
GB201207039D0 (en) 2012-04-23 2012-06-06 British American Tobacco Co Heating smokeable material
GB2533135B (en) 2014-12-11 2020-11-11 Nicoventures Holdings Ltd Aerosol provision systems
GB201511349D0 (en) 2015-06-29 2015-08-12 Nicoventures Holdings Ltd Electronic aerosol provision systems
GB201511361D0 (en) 2015-06-29 2015-08-12 Nicoventures Holdings Ltd Electronic vapour provision system
US11924930B2 (en) 2015-08-31 2024-03-05 Nicoventures Trading Limited Article for use with apparatus for heating smokable material
US20170055584A1 (en) 2015-08-31 2017-03-02 British American Tobacco (Investments) Limited Article for use with apparatus for heating smokable material
GB2542838B (en) 2015-10-01 2022-01-12 Nicoventures Trading Ltd Aerosol provision system
US20170119046A1 (en) 2015-10-30 2017-05-04 British American Tobacco (Investments) Limited Apparatus for Heating Smokable Material
US11744964B2 (en) 2016-04-27 2023-09-05 Nicoventures Trading Limited Electronic aerosol provision system and vaporizer therefor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399621B1 (en) * 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
US6472528B1 (en) 1999-08-10 2002-10-29 Neurocrine Biosciences, Inc. Synthesis of substituted pyrazolopyrimidines
US6485746B1 (en) * 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
SK2782002A3 (en) * 1999-09-02 2003-04-01 Neurocrine Biosciences Inc Polymorphs of N-methyl-N-[3-[3-(2-thienylcarbonyl)-pyrazol- [1,5-alpha]-pyrimidin-7-yl]phenyl]acetamide and compositions and methods related thereto
US6384221B1 (en) * 1999-09-02 2002-05-07 Neurocrine Biosciences, Inc. Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
JP2001177971A (ja) * 1999-12-20 2001-06-29 Auto Network Gijutsu Kenkyusho:Kk 回転接続装置
AU2003268212B2 (en) * 2002-08-26 2008-08-14 Neurocrine Biosciences, Inc. Novel polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-YL}phenyl)acetamide and compositions and methods related thereto

Also Published As

Publication number Publication date
KR101063033B1 (ko) 2011-09-07
WO2004018476A1 (en) 2004-03-04
ZA200501125B (en) 2006-07-26
JP2010070561A (ja) 2010-04-02
JP4522859B2 (ja) 2010-08-11
BR0313695A (pt) 2005-06-21
CA2493359A1 (en) 2004-03-04
NZ538027A (en) 2007-08-31
CA2493359C (en) 2009-10-27
AU2003268212B2 (en) 2008-08-14
CN1319974C (zh) 2007-06-06
EP1532152B1 (de) 2006-10-25
US20040116446A1 (en) 2004-06-17
AU2003268212A1 (en) 2004-03-11
TNSN05058A1 (en) 2007-05-14
US6903106B2 (en) 2005-06-07
TW200406404A (en) 2004-05-01
US20050153988A1 (en) 2005-07-14
EA200500421A1 (ru) 2005-08-25
PT1532152E (pt) 2007-02-28
AR044191A1 (es) 2005-09-07
JP2005538149A (ja) 2005-12-15
US7459458B2 (en) 2008-12-02
IS7769A (is) 2005-03-23
MA27519A1 (fr) 2005-09-01
DE60309332T2 (de) 2007-05-24
ECSP055703A (es) 2005-05-30
MXPA05002251A (es) 2005-06-08
CN1678614A (zh) 2005-10-05
DK1532152T3 (da) 2007-02-26
IL166621A (en) 2012-02-29
PL374436A1 (en) 2005-10-17
NO20050615L (no) 2005-03-22
PE20040979A1 (es) 2005-01-07
IL166621A0 (en) 2006-01-15
EP1532152A1 (de) 2005-05-25
HK1071373A1 (en) 2005-07-15
ATE343581T1 (de) 2006-11-15
HRP20050288A2 (en) 2006-10-31
TWI288135B (en) 2007-10-11
KR20050059082A (ko) 2005-06-17
ES2274260T3 (es) 2007-05-16
AP2005003220A0 (en) 2005-03-31
DE60309332D1 (de) 2006-12-07

Similar Documents

Publication Publication Date Title
CA2493359C (en) Novel polymorph of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-.alpha.]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
DE69303569T2 (de) Arylalkyl(thio)amide mit Melatonin-Rezeptor-Selektivität und Prozess zu ihrer Darstellung
US6384221B1 (en) Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
JP4592241B2 (ja) N−メチル−N−(3−{3−[2−チエニルカルボニル]−ピラゾール−[1,5−α]−ピリミジン−7−イル}フェニル)アセトアミドの多形相ならびにそれに関連する組成物および方法
HK1071373B (en) Novel polymorph of n-methyl-n-(3- 3- 2-thienylcarbonyl-pyrazol- 1,5-alpha-pyrimidin-7-yl phenyl)acetamide and compositions and methods related thereto
US7304069B2 (en) Hydrate of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5α]-pyrimidin-7-yl}phenyl)acetamide and processes and methods related thereto
JP4845139B2 (ja) エナンチオマー的に純粋なヘキサヒドロピロロシクロペンタピリジン誘導体
HK1071077A (en) Reactions of polymorphs of n-methyl-n-(3-(3-(2-thienylcarbonyl)-pyrazol-(1,5-alpha)-pyrimidin-7-yl)phenyl)acetamide